University Of Rome Tor Vergata

This study will enroll 290 adults who have had a stem cell transplant and are at risk for CMV infection. Researchers will measure different virus markers in the blood to see which ones best predict when CMV becomes active and when treatment is needed. The goal is to improve monit…

This study aims to learn more about how patients with chronic hepatitis D (HDV) respond to a treatment called bulevirtide (BLV). Researchers will analyze existing and future blood samples from about 220 patients to see how well the drug lowers the virus and to compare different l…